The most relevant challenge concerning the semi-solid extrusion 3D printing (SSE) pharmaceutical application is the development of versatile inks that can bypass the limitations of drug-matrix combinations. The present study aims to elucidate how physicochemical properties of different Active Pharmaceutical Ingredients (APIs) influence the performance of an alginate hydrogel-ink, as a function of drug concentrations (5 or 10% w/V). Precrosslinked alginate was used as matrix, while different NSAIDs (i.e., Ibuprofen, Ketoprofen, and Ketoprofen lysine salt) were used as model drugs, exploiting their differences in water solubility to obtain solubilized or dispersed drug. The match of FT-IR and rheological characterizations highlighted how drug solubilization in polymer matrix can generate chemical interaction leading to alteration of hydrogel entanglement, greater at higher drug concentration. Nevertheless, it was possible to reach optimal printability for all developed inks (tablet mass variation less than 10%), ensuring high encapsulation efficiency (>90%) for all matrices except for the ink loaded with 10% w/V of solubilized drug because the excessive entanglement disruption led to matrix leakage during post-printing. Release studies showed that all tablets had similar release behavior governed by the polymer matrix with a Super Case II transport. These results underlined the potentialities of the developed alginate matrix as a versatile SSE ink for compounding applications.
Semisolid extrusion 3D printing for pharmaceutical compounding: influence of active ingredients on alginate-based inks and tailored-dosage forms properties
Falcone, Giovanni
;Amante, Chiara;Sardo, Carla;Del Gaudio, Pasquale;Aquino, Rita P.;Russo, Paola
2026
Abstract
The most relevant challenge concerning the semi-solid extrusion 3D printing (SSE) pharmaceutical application is the development of versatile inks that can bypass the limitations of drug-matrix combinations. The present study aims to elucidate how physicochemical properties of different Active Pharmaceutical Ingredients (APIs) influence the performance of an alginate hydrogel-ink, as a function of drug concentrations (5 or 10% w/V). Precrosslinked alginate was used as matrix, while different NSAIDs (i.e., Ibuprofen, Ketoprofen, and Ketoprofen lysine salt) were used as model drugs, exploiting their differences in water solubility to obtain solubilized or dispersed drug. The match of FT-IR and rheological characterizations highlighted how drug solubilization in polymer matrix can generate chemical interaction leading to alteration of hydrogel entanglement, greater at higher drug concentration. Nevertheless, it was possible to reach optimal printability for all developed inks (tablet mass variation less than 10%), ensuring high encapsulation efficiency (>90%) for all matrices except for the ink loaded with 10% w/V of solubilized drug because the excessive entanglement disruption led to matrix leakage during post-printing. Release studies showed that all tablets had similar release behavior governed by the polymer matrix with a Super Case II transport. These results underlined the potentialities of the developed alginate matrix as a versatile SSE ink for compounding applications.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


